NCI | Technology Transfer

T CELL RECEPTORS RECOGNIZING MUTATED P53

Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53

Costa Rica
2025-0153
Filed on 2025-04-24

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Japan
2025-071352
Filed on 2025-04-23

PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

European Patent
23820358.2
Filed on 2025-01-07

PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Israel
317206
Filed on 2024-11-24

NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN
RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS

Read more about NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS

Patent Cooperation Treaty
PCT/US2025/029169
Filed on 2025-05-13

ANTI-MUTATED KRAS T CELL RECEPTORS

Read more about ANTI-MUTATED KRAS T CELL RECEPTORS

US Application 19/185,602
Filed on 2025-04-22

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Australia
2025202532
Filed on 2025-04-09

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

US Application 19/185,924
Filed on 2025-04-22

NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

South Korea
10-2025-7009189
Filed on 2025-03-20

NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Japan
2025-039507
Filed on 2025-03-12

Subscribe to NCI